Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE (plecanatide) in China Life Science Investing
ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement Pharmaceutical Investing
Bellerophon Announces Results of Interim Analysis of Phase 3 INOvation-1 Study Evaluating INOpulse for Treatment of Pulmonary Arterial Hypertension Pharmaceutical Investing
OncoMed Announces Second Quarter 2018 Financial Results and Operational Highlights Pharmaceutical Investing
QIAGEN Creates Collaboration with Japan’s Largest Clinical Laboratory Testing Company, SRL, to Accelerate Launch of Companion Diagnostics Genetics Investing
XELJANZ (tofacitinib citrate) Receives Marketing Authorization in the European Union for Moderately to Severely Active Ulcerative Colitis Pharmaceutical Investing
